KIAA0247 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.392350E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.200400E-03
Normal-vs-Stage2
2.046500E-02
Normal-vs-Stage3
3.958400E-02
Normal-vs-Stage4
4.273600E-01
Stage1-vs-Stage2
1.660780E-01
Stage1-vs-Stage3
8.586600E-01
Stage1-vs-Stage4
9.599500E-02
Stage2-vs-Stage3
1.972000E-01
Stage2-vs-Stage4
2.781000E-01
Stage3-vs-Stage4
1.922240E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.143800E-03
Normal-vs-AfricanAmerican
4.072400E-01
Normal-vs-Asian
3.331700E-02
Caucasian-vs-AfricanAmerican
4.803400E-01
Caucasian-vs-Asian
4.797000E-01
AfricanAmerican-vs-Asian
2.863200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.596010E-02
Normal-vs-Female
1.625640E-02
Male-vs-Female
4.245400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.309000E-01
Normal-vs-Age(41-60Yrs)
8.911700E-02
Normal-vs-Age(61-80Yrs)
5.143800E-03
Normal-vs-Age(81-100Yrs)
3.563200E-03
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.720200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.533800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.973200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.430750E-04
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.006310E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.659000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.167960E-02
Normal-vs-Daily Drinker
2.535200E-03
Normal-vs-Weekly Drinker
2.072400E-02
Normal-vs-Occasional Drinker
6.102400E-03
Normal-vs-Social Drinker
2.856100E-02
Non Drinker-vs-Daily Drinker
3.789000E-01
Non Drinker-vs-Weekly Drinker
7.469600E-01
Non Drinker-vs-Occasional Drinker
6.079800E-01
Non Drinker-vs-Social Drinker
1.595620E-01
Daily Drinker-vs-Weekly Drinker
2.726600E-01
Daily Drinker-vs-Occasional Drinker
1.548550E-01
Daily Drinker-vs-Social Drinker
2.407500E-02
Weekly Drinker-vs-Occasional Drinker
8.970400E-01
Weekly Drinker-vs-Social Drinker
3.151600E-01
Occasional Drinker-vs-Social Drinker
2.926200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.566150E-01
Normal-vs-Grade 2
1.001780E-02
Normal-vs-Grade 3
1.695710E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.332380E-01
Grade 1-vs-Grade 3
8.459800E-02
Grade 1-vs-Grade 4
1.566150E-01
Grade 2-vs-Grade 3
6.761400E-01
Grade 2-vs-Grade 4
1.001780E-02
Grade 3-vs-Grade 4
1.695710E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.408490E-02
Normal-vs-NonDiabetic
5.224200E-03
Diabetic-vs-NonDiabetic
8.516400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.218220E-02
Normal-vs-NoPancreatitis
8.080000E-03
Pancreatitis-vs-NoPancreatitis
8.246200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.135950E-02
Normal-vs-N1
1.961730E-02
N0-vs-N1
1.371150E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.991940E-02
Normal-vs-TP53-NonMutant
9.396500E-03
TP53-Mutant-vs-TP53-NonMutant
3.391000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
